MassMutual Private Wealth & Trust’s Amylyx Pharmaceuticals AMLX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio AMLX Stock Details AMLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$10.3K	Sell	354 -66	-16%	-$1.75K	﹤0.01%	1319
2026 Q2	$7.54K	Buy	420 +138	+49%	+$2.13K	﹤0.01%	1522
2026 Q1	$3.92K	Buy	282 +129	+84%	+$1.82K	﹤0.01%	1762
2025 Q4	$1.85K	Sell	153 -87	-36%	-$1.18K	﹤0.01%	2015
2025 Q3	$3.26K	Buy	+240	New	+$2.26K	﹤0.01%	1841

Other funds holding AMLX

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

MassMutual Private Wealth & Trust's AMLX Position: Q3 2026 in Review

MassMutual Private Wealth & Trust reduced its Amylyx Pharmaceuticals (AMLX) stake by 16% in Q3 2026, selling an estimated $1.75K and leaving 354 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1319.

MassMutual Private Wealth & Trust first reported a position in AMLX in Q3 2025 and has held it in 5 quarters since. 111 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.

MassMutual Private Wealth & Trust held 354 shares of Amylyx Pharmaceuticals worth $10.3K as of Q3 2026.
MassMutual Private Wealth & Trust sold 66 Amylyx Pharmaceuticals shares in Q3 2026, an estimated $1.75K.
Amylyx Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1319 holding.
MassMutual Private Wealth & Trust first reported a position in Amylyx Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
111 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.